CAPT James Gayton

CAPT James Gayton serves as a key procurement lead within the Naval Medical Logistics Command (N62645), overseeing the acquisition of mission-critical medical technologies that sustain U.S. Navy and Marine Corps operational readiness. He manages a diverse portfolio of contracts focused on diagnostic instrumentation, biotechnological research, and surgical supply systems, ensuring timely delivery of life-sustaining equipment to global theaters. His role is central to the Command’s mission of maintaining a resilient, responsive medical logistics pipeline, with an emphasis on point-of-care diagnostics, advanced clinical tools, and next-generation medical devices that support combat casualty care and preventive medicine initiatives. Gayton collaborates with a broad spectrum of vendors, including manufacturers of analytical laboratory instruments, biotechnology R&D firms, and surgical appliance suppliers. While no single contractor dominates his portfolio, he consistently engages with both large defense contractors and specialized medical technology firms capable of meeting stringent military specifications. His contracting approach prioritizes technical performance, supply chain reliability, and rapid deployment capabilities, fostering long-term partnerships with vendors who can deliver compliant, high-integrity medical systems under austere conditions. Gayton’s procurement activity is entirely non-set-aside, with 100% of awards issued under full and open competition. This reflects a strategic emphasis on accessing the broadest possible pool of technical expertise and innovation, rather than socioeconomic set-asides. While small business participation is not formally prioritized through set-aside mechanisms, he evaluates all vendors based on technical merit, past performance, and capacity to meet DoD medical logistics requirements. His primary NAICS focus spans analytical laboratory instrument manufacturing, biotechnology R&D, surgical appliance production, and physical/engineering life sciences research. This underscores his deep expertise in procuring cutting-edge diagnostic systems, laboratory automation tools, and clinical support technologies essential to modern military medicine. His portfolio reflects a deliberate alignment with emerging medical technologies that enhance field-deployable diagnostics and evidence-based clinical decision-making.